HSBC Holdings
ONCR

HSBC Holdings’s Oncorus, Inc. ONCR Stock Holding History

HSBC Holdings’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26,452
Closed -$8.73K – 2837
2023
Q1 		$8.73K Hold
26,452
– – ﹤0.01% 2624
2022
Q4 		$7.14K Buy
26,452
+32
+0.1% +$18 ﹤0.01% 3034
2022
Q3 		$22K Hold
26,420
– – ﹤0.01% 2868
2022
Q2 		$34K Buy
26,420
+4,626
+21% +$6.28K ﹤0.01% 3168
2022
Q1 		$39K Buy
+21,794
New +$61.1K ﹤0.01% 3212
2021
Q1 		– Sell
-6,315
Closed -$204K – 3230
2020
Q4 		$204K Buy
+6,315
New +$146K ﹤0.01% 2810

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

HSBC Holdings's ONCR Position: Q2 2023 in Review

HSBC Holdings sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 26,452 shares — an estimated $8.73K sold.

HSBC Holdings first reported a position in ONCR in Q4 2020 and held it in 6 quarters. The position peaked at $204K in Q4 2020. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • HSBC Holdings reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • HSBC Holdings sold 26,452 Oncorus, Inc. shares in Q2 2023, an estimated $8.73K.
  • HSBC Holdings first reported a position in Oncorus, Inc. in Q4 2020 and held it in 6 quarters.
  • HSBC Holdings's Oncorus, Inc. position peaked at $204K in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on HSBC Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.